Trials / Not Yet Recruiting
Not Yet RecruitingNCT06748144
IO Vancomycin Spine
Intraosseous vs. Intravenous Vancomycin Administration in Spine Surgery
- Status
- Not Yet Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- The Methodist Hospital Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intraosseous Vancomycin | The intervention is specific to the method of administration that will be used when giving the dose of antibiotic vancomycin which is done to prevent infection following surgery. |
| DRUG | Intravenous Vancomycin | This is the standard method of giving the antibiotic vancomycin to patients undergoing surgery across many specialties in order to prevent infection. |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-04-01
- Completion
- 2030-04-01
- First posted
- 2024-12-27
- Last updated
- 2026-03-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06748144. Inclusion in this directory is not an endorsement.